Martin Shkreli’s notorious mixture of contempt and bemusement was on full-display at a Congressional hearing over drug prices on Thursday.
The controversial pharmaceutical executive attended the hearing to which he had been subpoenaed but said almost nothing in response to questions about his business practices. Because Shkreli is facing criminal charges of defrauding investors, he invoked his Fifth Amendment right against self-incrimination.
Those charges are not related to his leadership of Turing Pharmaceuticals, the firm that is one of the subjects of a price gouging investigation by Congress, but it was apparently related enough that his attorney advised him to remain silent and Congress has not sought any legal remedy yet to force him to talk.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
